Bayer Aktiengesellschaft (FRA:BAYN)
Germany
· Delayed Price · Currency is EUR 26.98
+0.70 (2.64%)
At close: Jun 27, 2025, 10:00 PM CET
Bayer Aktiengesellschaft Employees
Bayer Aktiengesellschaft had 91,864 employees as of December 31, 2024. The number of employees decreased by 5,067 or -5.23% compared to the previous year.
Employees
91,864
Change (1Y)
-5,067
Growth (1Y)
-5.23%
Revenue / Employee
€512,505
Profits / Employee
€35,792
Market Cap
26.50B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 91,864 | -5,067 | -5.23% |
| Dec 31, 2023 | 96,931 | -991 | -1.01% |
| Dec 31, 2022 | 97,922 | 1,972 | 2.06% |
| Dec 31, 2021 | 95,950 | -5 | -0.01% |
| Dec 31, 2020 | 95,955 | -2,782 | -2.82% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| SAP SE | 109,121 |
| Siemens Aktiengesellschaft | 327,000 |
| Deutsche Telekom AG | 198,194 |
| Allianz SE | 156,626 |
| Rheinmetall AG | 28,539 |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
| Siemens Energy AG | 98,000 |
| Siemens Healthineers AG | 72,000 |
Bayer Aktiengesellschaft News
- 1 day ago - Court Approves $38M Cash Settlement Against Bayer AG in Hard-Fought Securities Class Action - GlobeNewsWire
- 1 day ago - Bayer, Regeneron get EU nod for Eylea's label extension - Seeking Alpha
- 3 days ago - Bayer share price is rising: does it have more upside? - Invezz
- 3 days ago - EY US & Bayer Win “Artificial Intelligence for Good” Award in 2025 AI Breakthrough Awards Program - GlobeNewsWire
- 5 days ago - Exelixis' Zanzalintinib Combo Boosts Survival In Colorectal Cancer, Stock Soars - Benzinga
- 10 days ago - Bayer’s stock is charting a 40% rebound after years of losses - Fortune
- 11 days ago - Bayer Files for Approval of gadoquatrane in the U.S. - Business Wire
- 11 days ago - Captain T Cell Joins Bayer Co.Lab Berlin to Accelerate Autologous and Allogeneic TCR-T Cell Therapy Programs for Cancer Patients - GlobeNewsWire